Tag: Innovent Biologics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Innovent Biologics Inc.

Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in ...

Added to Collection on: 2021-08-18 00:13:36

Tags for this article:

Drugs
Clinical medicine
Medicine
Cancer immunotherapy
Sintilimab
Anti-obesity medication
Oxyntomodulin
Biosimilar
Diabetes
Medroxyprogesterone acetate
Obesity
Glucagon-like peptide-1 receptor
GLP-1
Innovent Biologics Inc.
Hongwei Jiang
Glucagon
Lei Qian
Linong Ji
China

Click the tags to see associated articles and topics

View Article Details
Bolt Biotherapeutics and Innovent Biologics Announce Collaboration to Develop Three New ...

Added to Collection on: 2021-08-26 20:03:45

Tags for this article:

Life Sciences
Clinical medicine
Medicine
Cancer immunotherapy
Biotechnology
Immunology
Virotherapy
Biopharmaceutical
Eli Lilly and Company
Sintilimab
Tumor microenvironment
Monoclonal antibody therapy
Bolt Biotherapeutics, Inc.
China
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent and Bolt Biotherapeutics Announce Collaboration to Develop Three New Oncology ...

Added to Collection on: 2021-08-27 00:00:00

Tags for this article:

Life Sciences
Clinical medicine
Medicine
Biotechnology
Immunology
Cancer immunotherapy
Monoclonal antibodies
Virotherapy
Biopharmaceutical
Sintilimab
Monoclonal antibody therapy
Tumor microenvironment
Bolt Biotherapeutics, Inc.
China
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Bolt Bio Partners With Innovent Biologics to Create Three New Cancer Treatments

Added to Collection on: 2021-08-28 09:54:43

Tags for this article:

Life Sciences
Clinical medicine
Health sciences
Cancer immunotherapy
Virotherapy
Biopharmaceutical
Monoclonal antibody therapy
Immune system
Immunotherapy
Bolt Biotherapeutics, Inc.
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL ... - PR Newswire

Added to Collection on: 2022-07-04 00:11:17

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Biotechnology
Autoimmune diseases
Monoclonal antibodies
Immunology
Diarrhea
Ulcerative colitis
Sintilimab
Biopharmaceutical
Biosimilar
China
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 ...

Added to Collection on: 2022-07-04 20:29:24

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Autoimmune diseases
Monoclonal antibodies
Biotechnology
Diarrhea
Immunology
Ulcerative colitis
Management of ulcerative colitis
Inflammatory bowel disease
Biopharmaceutical
China
Innovent Biologics Inc.
I Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Announces First Patient Dosing in Australia in Phase 1 Study of IBI363 (PD-1/IL-2 ...

Added to Collection on: 2022-08-24 10:20:37

Tags for this article:

Medicine
Medical specialties
Clinical medicine
Cancer treatments
Immune system
Sintilimab
Programmed cell death protein 1
PD-L1
Immune checkpoint
Interleukin 2
Immunotherapy
Checkpoint inhibitor
Australia
China
Innovent Biologics Inc.
I Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent's MSCI ESG Rating Upgraded to A - PR Newswire

Added to Collection on: 2023-11-30 23:58:46

Tags for this article:

Biotechnology
Specialty drugs
Cancer immunotherapy
Sintilimab
Eli Lilly and Company
Biosimilar
Biopharmaceutical
MSCI
Incyte
Pharmaceutical industry in India
Bevacizumab
Yu Dechao
Research LLC
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent Announces Retirement of CFO and Appointment of New CFO - Yahoo Finance

Added to Collection on: 2024-02-05 18:34:47

Tags for this article:

Specialty drugs
Orphan drugs
Monoclonal antibodies
Angiogenesis inhibitors
Cancer immunotherapy
Sintilimab
Eli Lilly and Company
Biosimilar
Biopharmaceutical
Incyte
Adalimumab
Bevacizumab
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting

Added to Collection on: 2024-04-08 13:51:56

Tags for this article:

Clusters of differentiation
Immunology
Immune system
Biotechnology
Cancer treatments
Bispecific monoclonal antibody
CD276
Epidermal growth factor receptor
CD28
Immune stimulating antibody conjugate
Monoclonal antibody
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details